As of now, specific details about Molecs' headquarters, last investment, and the involved investors remain undisclosed. However, the focus on the impactful sectors they operate in, combined with their innovative approach to leveraging genomics data for precision medicine, signifies a promising venture with significant potential for growth and disruption within the healthcare and life sciences industry. It would be worthwhile for venture capitalists to monitor Molecs closely as they navigate the burgeoning field of clinical genomics and decision support platforms.
Molecs
We learn from the puzzling nature of genome.
Founded 2019
Istanbul
1 employees
AI, Deep Tech +4
General Information
Company Name
Molecs
Founded Year
2019
Location
Istanbul
Employees
1
Industries
AI, Deep Tech, Enterprise Software +3
Social
BounceWatch is an independent company data service, not affiliated with Molecs. To contact Molecs, visit molecs.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Molecs compare?
A PDF of Molecs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Molecs soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Molecs on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Molecs
Business keywords: Genomics, Clinical analysis, Precision medicine, Oncology, Decision support, Cloud platform, Clinical genomics, Health professionals, Molecular biology, Medical technology, Data science
No funding data available for Molecs yet.
Molecs Alternatives & Competitors
View All Alternatives
Molecs vs
GenXys
Canada
Digital Health Tech leader with pharmacogenetics expertise providing excellent medication decision s...
Seed
18 employees
Digital Health, Enterprise Software
Molecs vs
MNM Bioscience
United States
From tumor genomes to AI-driven drug discovery
Seed
2 employees
AI, Biotechnology
Molecs vs
Aiforia Technologies
Finland
Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.
IPO
81 employees
AI, Biotechnology
FAQ About Molecs
We learn from the puzzling nature of genome.
Molecs was founded in 2019.
Molecs is headquartered in Istanbul.
Molecs operates in AI, Deep Tech, Enterprise Software, Life Sciences, Professional Services Tech and SaaS. Its work centres on Genomics, Clinical analysis, Precision medicine and Oncology.
Molecs has approximately 1 employees.
Top alternatives and competitors to Molecs include GenXys, MNM Bioscience, Aiforia Technologies, Singularity.AI, Axia Medicine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Molecs and GenXys are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Molecs, https://www.bouncewatch.com/company/molecs, updated 10 October 2024. When citing, please name BounceWatch and link this page.
